|
Delaware
|
06-1059331
|
|
(State
or other jurisdiction
|
(I.R.S.
Employer
|
|
of
incorporation or organization)
|
Identification
No.)
|
|
Large
accelerated filer [X]
|
Accelerated
filer [ ]
|
||
|
Non-accelerated
filer [ ]
|
Smaller
Reporting Company [ ]
|
|
Page
No.
|
||
|
PART
I.
|
FINANCIAL
INFORMATION
|
|
|
Item
1. Financial Statements
|
||
|
Consolidated
Statements of Income
|
||
|
Consolidated
Balance Sheets
|
||
|
Consolidated
Statements of Comprehensive Income and Changes in Shareholders'
Equity
|
||
|
Consolidated
Statements of Cash Flows
|
||
|
Notes
to the Consolidated Financial Statements
|
||
|
Item
2. Management's Discussion and Analysis of Financial Condition and Results
of Operations
|
||
|
Item
3. Quantitative and Qualitative Disclosures About Market Risk
|
||
|
Item
4. Controls and Procedures
|
||
|
PART
II.
|
OTHER
INFORMATION
|
|
|
Item
1. Legal Proceedings
|
||
|
Item
1A. Risk Factors
|
||
|
Item
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
|
|
|
Item
6. Exhibits
|
||
|
SIGNATURE
|
||
|
EXHIBIT
INDEX
|
||
|
CIGNA
Corporation
|
||||||||||||||||
|
Consolidated
Statements of Income
|
||||||||||||||||
|
Unaudited
|
Unaudited
|
|||||||||||||||
|
Three
Months Ended
|
Nine
Months Ended
|
|||||||||||||||
|
September
30,
|
September
30,
|
|||||||||||||||
|
(In millions,
except per share amounts)
|
2008
|
2007
|
2008
|
2007
|
||||||||||||
|
Revenues
|
||||||||||||||||
|
Premiums
and fees
|
$ | 4,112 | $ | 3,744 | $ | 12,165 | $ | 11,209 | ||||||||
|
Net
investment income
|
272 | 281 | 802 | 840 | ||||||||||||
|
Mail
order pharmacy revenues
|
300 | 278 | 882 | 826 | ||||||||||||
|
Other
revenues
|
191 | 83 | 463 | 256 | ||||||||||||
|
Realized
investment gains (losses)
|
(23 | ) | 27 | (28 | ) | 37 | ||||||||||
|
Total
revenues
|
4,852 | 4,413 | 14,284 | 13,168 | ||||||||||||
|
Benefits
and Expenses
|
||||||||||||||||
|
Health
Care medical claims expense
|
1,806 | 1,659 | 5,450 | 5,107 | ||||||||||||
|
Other
benefit expenses
|
1,062 | 837 | 2,907 | 2,507 | ||||||||||||
|
Mail
order pharmacy cost of goods sold
|
238 | 225 | 704 | 669 | ||||||||||||
|
Guaranteed
minimum income benefits expense
|
98 | - | 353 | 120 | ||||||||||||
|
Other
operating expenses
|
1,416 | 1,190 | 4,152 | 3,522 | ||||||||||||
|
Total
benefits and expenses
|
4,620 | 3,911 | 13,566 | 11,925 | ||||||||||||
|
Income
from Continuing Operations
|
||||||||||||||||
|
before
Income Taxes
|
232 | 502 | 718 | 1,243 | ||||||||||||
|
Income
taxes (benefits):
|
||||||||||||||||
|
Current
|
65 | 125 | 274 | 420 | ||||||||||||
|
Deferred
|
(3 | ) | 14 | (54 | ) | (34 | ) | |||||||||
|
Total
taxes
|
62 | 139 | 220 | 386 | ||||||||||||
|
Income
from Continuing Operations
|
170 | 363 | 498 | 857 | ||||||||||||
|
Income
(Loss) from Discontinued Operations, Net of Taxes
|
1 | 2 | 3 | (5 | ) | |||||||||||
|
Net
Income
|
$ | 171 | $ | 365 | $ | 501 | $ | 852 | ||||||||
|
Earnings
Per Share - Basic:
|
||||||||||||||||
|
Income
from continuing operations
|
$ | 0.62 | $ | 1.30 | $ | 1.80 | $ | 3.01 | ||||||||
|
Income
(loss) from discontinued operations
|
0.01 | - | 0.01 | (0.02 | ) | |||||||||||
|
Net
income
|
$ | 0.63 | $ | 1.30 | $ | 1.81 | $ | 2.99 | ||||||||
|
Earnings
Per Share - Diluted:
|
||||||||||||||||
|
Income
from continuing operations
|
$ | 0.62 | $ | 1.28 | $ | 1.78 | $ | 2.95 | ||||||||
|
Income
(loss) from discontinued operations
|
- | - | 0.02 | (0.01 | ) | |||||||||||
|
Net
income
|
$ | 0.62 | $ | 1.28 | $ | 1.80 | $ | 2.94 | ||||||||
|
Dividends
Declared Per Share
|
$ | - | $ | 0.010 | $ | 0.040 | $ | 0.028 | ||||||||
|
The
accompanying Notes to the Consolidated Financial
Statements are an integral part of these statements.
|
||||||||||||||||
|
CIGNA Corporation
|
||||||||||||||||
|
Consolidated
Balance Sheets
|
||||||||||||||||
|
Unaudited
|
||||||||||||||||
|
As
of
September
30,
|
As
of
December
31,
|
|||||||||||||||
|
(In millions,
except per share amounts)
|
2008
|
2007
|
||||||||||||||
|
Assets
|
||||||||||||||||
|
Investments:
|
||||||||||||||||
|
Fixed
maturities, at fair value (amortized cost, $11,777;
$11,409)
|
$ | 11,892 | $ | 12,081 | ||||||||||||
|
Equity
securities, at fair value (cost, $140; $127)
|
127 | 132 | ||||||||||||||
|
Commercial
mortgage loans
|
3,558 | 3,277 | ||||||||||||||
|
Policy
loans
|
1,553 | 1,450 | ||||||||||||||
|
Real
estate
|
51 | 49 | ||||||||||||||
|
Other
long-term investments
|
576 | 520 | ||||||||||||||
|
Short-term
investments
|
64 | 21 | ||||||||||||||
|
Total
investments
|
17,821 | 17,530 | ||||||||||||||
|
Cash
and cash equivalents
|
1,078 | 1,970 | ||||||||||||||
|
Accrued
investment income
|
251 | 233 | ||||||||||||||
|
Premiums,
accounts and notes receivable
|
1,627 | 1,405 | ||||||||||||||
|
Reinsurance
recoverables
|
7,048 | 7,331 | ||||||||||||||
|
Deferred
policy acquisition costs
|
816 | 816 | ||||||||||||||
|
Property
and equipment
|
791 | 625 | ||||||||||||||
|
Deferred
income taxes, net
|
1,010 | 794 | ||||||||||||||
|
Goodwill
|
2,859 | 1,783 | ||||||||||||||
|
Other
assets, including other intangibles
|
1,089 | 536 | ||||||||||||||
|
Separate
account assets
|
6,386 | 7,042 | ||||||||||||||
|
Total
assets
|
$ | 40,776 | $ | 40,065 | ||||||||||||
|
Liabilities
|
||||||||||||||||
|
Contractholder
deposit funds
|
$ | 8,555 | $ | 8,594 | ||||||||||||
|
Future
policy benefits
|
8,069 | 8,147 | ||||||||||||||
|
Unpaid
claims and claim expenses
|
4,089 | 4,127 | ||||||||||||||
|
Health
Care medical claims payable
|
1,054 | 975 | ||||||||||||||
|
Unearned
premiums and fees
|
457 | 496 | ||||||||||||||
|
Total
insurance and contractholder liabilities
|
22,224 | 22,339 | ||||||||||||||
|
Accounts
payable, accrued expenses and other liabilities
|
5,105 | 4,127 | ||||||||||||||
|
Short-term
debt
|
315 | 3 | ||||||||||||||
|
Long-term
debt
|
2,090 | 1,790 | ||||||||||||||
|
Nonrecourse
obligations
|
14 | 16 | ||||||||||||||
|
Separate
account liabilities
|
6,386 | 7,042 | ||||||||||||||
|
Total
liabilities
|
36,134 | 35,317 | ||||||||||||||
|
Contingencies
— Note 15
|
||||||||||||||||
|
Shareholders’
Equity
|
||||||||||||||||
|
Common
stock (par value per share, $0.25; shares issued, 351)
|
88 | 88 | ||||||||||||||
|
Additional
paid-in capital
|
2,498 | 2,474 | ||||||||||||||
|
Net
unrealized appreciation (depreciation), fixed maturities
|
$ | (107 | ) | $ | 140 | |||||||||||
|
Net
unrealized appreciation, equity securities
|
9 | 7 | ||||||||||||||
|
Net
unrealized depreciation, derivatives
|
(16 | ) | (19 | ) | ||||||||||||
|
Net
translation of foreign currencies
|
(18 | ) | 61 | |||||||||||||
|
Postretirement
benefits liability adjustment
|
(122 | ) | (138 | ) | ||||||||||||
|
Accumulated
other comprehensive income (loss)
|
(254 | ) | 51 | |||||||||||||
|
Retained
earnings
|
7,582 | 7,113 | ||||||||||||||
|
Less
treasury stock, at cost
|
(5,272 | ) | (4,978 | ) | ||||||||||||
|
Total
shareholders’ equity
|
4,642 | 4,748 | ||||||||||||||
|
Total
liabilities and shareholders’ equity
|
$ | 40,776 | $ | 40,065 | ||||||||||||
|
Shareholders’
Equity Per Share
|
$ | 17.05 | $ | 16.98 | ||||||||||||
|
The
accompanying Notes to the Consolidated Financial
Statements are an integral part of these statements.
|
||||||||||||||||
|
CIGNA Corporation
|
||||||||
|
Consolidated
Statements of Comprehensive Income and Changes in Shareholders’
Equity
|
||||||||
|
(In millions)
|
||||||||
|
Unaudited
|
||||||||||||||||
|
Three
Months Ended September 30,
|
2008
|
2007
|
||||||||||||||
|
Compre-
|
Share-
|
Compre-
|
Share-
|
|||||||||||||
|
hensive
|
holders’
|
hensive
|
holders’
|
|||||||||||||
|
Income
|
Equity
|
Income
|
Equity
|
|||||||||||||
|
Common
Stock, September 30
|
$ | 88 | $ | 88 | ||||||||||||
|
Additional
Paid-In Capital, July 1
|
2,493 | 2,460 | ||||||||||||||
|
Effect
of issuance of stock for employee benefit plans
|
5 | 5 | ||||||||||||||
|
Additional
Paid-In Capital, September 30
|
2,498 | 2,465 | ||||||||||||||
|
Accumulated
Other Comprehensive Loss, July 1
|
(84 | ) | (257 | ) | ||||||||||||
|
Net
unrealized appreciation (depreciation), fixed maturities
|
$ | (133 | ) | (133 | ) | $ | 51 | 51 | ||||||||
|
Net
unrealized appreciation (depreciation), equity securities
|
2 | 2 | (3 | ) | (3 | ) | ||||||||||
|
Net
unrealized appreciation (depreciation) on securities
|
(131 | ) | 48 | |||||||||||||
|
Net
unrealized appreciation (depreciation), derivatives
|
14 | 14 | (1 | ) | (1 | ) | ||||||||||
|
Net
translation of foreign currencies
|
(56 | ) | (56 | ) | 18 | 18 | ||||||||||
|
Postretirement
benefits liability adjustment
|
3 | 3 | 16 | 16 | ||||||||||||
|
Other
comprehensive income (loss)
|
(170 | ) | 81 | |||||||||||||
|
Accumulated
Other Comprehensive Loss, September 30
|
(254 | ) | (176 | ) | ||||||||||||
|
Retained
Earnings, July 1
|
7,412 | 6,513 | ||||||||||||||
|
Net
income
|
171 | 171 | 365 | 365 | ||||||||||||
|
Effects
of issuance of stock for employee benefit plans
|
(1 | ) | (10 | ) | ||||||||||||
|
Common
dividends declared
|
- | (3 | ) | |||||||||||||
|
Retained
Earnings, September 30
|
7,582 | 6,865 | ||||||||||||||
|
Treasury
Stock, July 1
|
(5,155 | ) | (4,795 | ) | ||||||||||||
|
Repurchase
of common stock
|
(125 | ) | (236 | ) | ||||||||||||
|
Other,
primarily issuance of treasury stock for employee
|
||||||||||||||||
|
benefit
plans
|
8 | 25 | ||||||||||||||
|
Treasury
Stock, September 30
|
(5,272 | ) | (5,006 | ) | ||||||||||||
|
Total
Comprehensive Income and Shareholders’ Equity
|
$ | 1 | $ | 4,642 | $ | 446 | $ | 4,236 | ||||||||
|
The
accompanying Notes to the Consolidated Financial
Statements are an integral part of these statements.
|
||||||||||||||||
|
CIGNA
Corporation
|
||||||||||||||||
|
Consolidated
Statements of Comprehensive Income and Changes in Shareholders’
Equity
|
||||||||||||||||
|
(In millions)
|
||||||||||||||||
|
Unaudited
|
||||||||||||||||
|
Nine
Months Ended September 30,
|
2008
|
2007
|
||||||||||||||
|
Compre-
|
Share-
|
Compre-
|
Share-
|
|||||||||||||
|
hensive
|
holders’
|
hensive
|
holders’
|
|||||||||||||
|
Income
|
Equity
|
Income
|
Equity
|
|||||||||||||
|
Common
Stock, January 1
|
$ | 88 | $ | 40 | ||||||||||||
|
Effect
of issuance of stock for stock split
|
- | 48 | ||||||||||||||
|
Common
Stock, September 30
|
88 | 88 | ||||||||||||||
|
Additional
Paid-In Capital, January 1
|
2,474 | 2,451 | ||||||||||||||
|
Effect
of issuance of stock for employee benefit plans
|
24 | 62 | ||||||||||||||
|
Effect
of issuance of stock for stock split
|
- | (48 | ) | |||||||||||||
|
Additional
Paid-In Capital, September 30
|
2,498 | 2,465 | ||||||||||||||
|
Accumulated
Other Comprehensive Income (Loss),
|
||||||||||||||||
|
January
1 prior to implementation effect
|
51 | (169 | ) | |||||||||||||
|
Implementation
effect of SFAS No.155
|
- | (12 | ) | |||||||||||||
|
Accumulated
Other Comprehensive Income (Loss),
|
||||||||||||||||
|
January
1 as adjusted
|
51 | (181 | ) | |||||||||||||
|
Net
unrealized depreciation, fixed maturities
|
$ | (247 | ) | (247 | ) | $ | (73 | ) | (73 | ) | ||||||
|
Net
unrealized appreciation (depreciation), equity securities
|
2 | 2 | (3 | ) | (3 | ) | ||||||||||
|
Net
unrealized depreciation on securities
|
(245 | ) | (76 | ) | ||||||||||||
|
Net
unrealized appreciation (depreciation), derivatives
|
3 | 3 | (11 | ) | (11 | ) | ||||||||||
|
Net
translation of foreign currencies
|
(79 | ) | (79 | ) | 23 | 23 | ||||||||||
|
Postretirement
benefits liability adjustment
|
16 | 16 | 69 | 69 | ||||||||||||
|
Other
comprehensive income (loss)
|
(305 | ) | 5 | |||||||||||||
|
Accumulated
Other Comprehensive Loss, September 30
|
(254 | ) | (176 | ) | ||||||||||||
|
Retained
Earnings, January 1 prior to
|
||||||||||||||||
|
implementation
effects
|
7,113 | 6,177 | ||||||||||||||
|
Implementation
effect of SFAS No. 155
|
- | 12 | ||||||||||||||
|
Implementation
effect of FIN 48
|
- | (29 | ) | |||||||||||||
|
Retained
Earnings, January 1 as adjusted
|
7,113 | 6,160 | ||||||||||||||
|
Net
income
|
501 | 501 | 852 | 852 | ||||||||||||
|
Effects
of issuance of stock for employee benefit plans
|
(21 | ) | (139 | ) | ||||||||||||
|
Common
dividends declared
|
(11 | ) | (8 | ) | ||||||||||||
|
Retained
Earnings, September 30
|
7,582 | 6,865 | ||||||||||||||
|
Treasury
Stock, January 1
|
(4,978 | ) | (4,169 | ) | ||||||||||||
|
Repurchase
of common stock
|
(347 | ) | (1,158 | ) | ||||||||||||
|
Other,
primarily issuance of treasury stock for employee
|
||||||||||||||||
|
benefit
plans
|
53 | 321 | ||||||||||||||
|
Treasury
Stock, September 30
|
(5,272 | ) | (5,006 | ) | ||||||||||||
|
Total
Comprehensive Income and Shareholders’ Equity
|
$ | 196 | $ | 4,642 | $ | 857 | $ | 4,236 | ||||||||
|
The
accompanying Notes to the Consolidated Financial
Statements are an integral part of these statements.
|
||||||||||||||||
|
CIGNA Corporation
|
||||||||
|
Consolidated
Statements of Cash Flows
|
||||||||
|
Unaudited
|
||||||||
|
(In millions)
| ||||||||